CBT's best-proven effect is on how much hot flashes bother and interfere with your life, more than on the raw number of flashes your body produces.

In randomized trials, group and self-help CBT programs significantly reduced how much women were bothered by hot flashes and night sweats, with effects lasting months, and also improved mood, sleep, and quality of life. Guidelines now recommend menopause-specific CBT as a genuine treatment option for hot flashes, not merely a coping tool, precisely because reducing bother and improving function is the outcome most women are actually seeking care for.

What to know about this answer

Position 1 holds that CBT treats the symptom experience, which is the actual clinical target most women seek care for. Position 2, articulated as a clinical boundary rather than a rejection of CBT, cautions that physiologically measured flash frequency generally does not fall much with CBT, so it should not be presented as equivalent to a drug.

What the research shows, and which source each finding rests on

In breast cancer survivors with problematic hot flushes and night sweats (n = 96), group cognitive behavioral therapy reduced the symptom problem rating by 1.67 points more than usual care at 9 weeks (95 percent CI -2.43 to -0.91, p < 0.0001), maintained at 26 weeks, with benefits to mood, sleep, and quality of life

B[1]

In general menopausal women (n = 140), both group cognitive behavioral therapy and guided self-help cognitive behavioral therapy reduced the symptom problem rating versus a no-treatment control at 6 weeks (adjusted mean differences 2.12 and 2.08 on a 1-10 scale, both p < 0.001), sustained at 26 weeks; night sweat frequency also fell

B[2]

NICE's November 2024 update recommends menopause-specific CBT for vasomotor symptoms and sleep, alongside hormone therapy or as an alternative when it is declined or contraindicated; The Menopause Society's 2023 statement also grades CBT as a Level I, recommended, treatment

A[3]

Where the real disagreement is

Each position is shown with its own sources. A position listed here is not necessarily the accepted view.

The flashes themselves barely change

Kelly Casperson, articulating a clinical boundary

Physiologically measured flash frequency generally does not fall much with cognitive behavioral therapy, and presenting it as equivalent to drug therapy conflates bother with frequency; she states that cognitive behavioral therapy is valuable but does not replace hormones, given the scale of the underlying hormone change.

B[1]B[2]

What would settle it: This is already reasonably resolved as a matter of what outcome is being measured, bother and interference versus raw frequency; a claimed conference finding that CBT beat hormone therapy for stopping mild hot flashes is unverified and contradicts the published hierarchy for moderate-to-severe symptoms, so it should not be treated as established.

What is really going on here

  1. If CBT is offered, is it menopause-specific CBT? The evidence base is for structured menopause-specific programs, including guided self-help, not generic counseling.

Questions for your doctor

  1. Is the CBT program you're recommending menopause-specific, following a structured protocol, not general counseling?
  2. Is group CBT, individual CBT, or guided self-help available to me, and does it matter which?
  3. Would combining CBT with a medical treatment make sense for me rather than choosing one or the other?
  4. How many sessions are typically needed before we'd expect to see benefit?

Questions with no answer yet

If physiologically measured hot flash frequency barely changes with cognitive behavioral therapy while the bother rating drops substantially, what is actually happening in the body or brain to make the same number of flashes feel less disruptive?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: The trials establishing this therapy's benefit measured the problem rating, meaning bother, interference, and distress, as the primary outcome, with frequency measured separately and changing less. The mechanism connecting the psychological intervention to the reduced bother rating is not detailed.

What would test it: Mechanistic studies measuring physiological arousal and attention alongside bother ratings during treatment, to identify what is actually changing.

Is there a version of this therapy, or a component within it, that could also reduce the raw frequency of flashes, not just the distress they cause, or is frequency simply not a modifiable target through a psychological intervention?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: This is framed as a genuine, stated clinical boundary, that the therapy is valuable but does not replace hormones given the scale of the underlying hormonal change, without any report of a trial that has tried to isolate a frequency-reducing component specifically.

What would test it: A trial testing modified therapy protocols specifically designed to target physiological flash frequency, not only the distress response.

An unverified conference claim that this therapy beat hormone therapy for stopping mild hot flashes contradicts the published hierarchy for moderate-to-severe symptoms. Could it actually outperform hormones specifically in a mild-symptom subgroup, even though it clearly does not for moderate-to-severe symptoms?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: This specific claim is explicitly labeled unverified and conference-level, noted as contradicting the published hierarchy for moderate-to-severe symptoms, while not ruling out a genuinely different result in a mild-symptom population that has not been separately tested.

What would test it: A properly designed, peer-reviewed trial comparing this therapy against hormone therapy specifically in women with mild, not moderate-to-severe, hot flashes.

Sources

  1. 1.Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial.Mann E et al., Lancet Oncol 2012 · Randomised trial
  2. 2.Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial.Ayers B et al., Menopause 2012 · Randomised trial
  3. 3.The 2023 nonhormone therapy position statement of The North American Menopause Society.NICE guideline NG23, updated 7 November 2024; The North American Menopause Society 2023 nonhormone therapy position statement, Menopause 2023 · Systematic review or guideline

The letter grades the type of study behind a claim, not the answer itself.

This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.

You are not imagining it

In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.

Start Free Mapping

Related questions

Related guides